Hijova E, Szabadosova V, Strojny L, Bomba A
Bratisl Lek Listy. 2014;115(2):76-9. doi: 10.4149/bll_2014_016.
Natural dietary compounds such as prebiotics modulate microbial composition and could prevent the colon cancer development as potential chemopreventive agent.
Effect of prebiotic-inulin on biochemical, microbial and chemopreventive markers were examined in Sprague-Dawley rats during experimental chemically dimethylhydrazine induced colon cancer development.
Rats were divided to 3 groups: control group (CG), group with dimethylhydrazine (DMH) and group with DMH and prebiotic (DMH+PRE). The efficacy of the prebiotic inulin (PRE) on the activities of β-glucuronidase, short chain fatty acids (SCFAs), counts of coliforms and lactobacilli, immunoreactivity of cyclooxygenase-2 (COX-2), transcription nuclear factor kappa beta (NFκB) and inducible nitric oxide synthase (iNOS) in colon tissue were examined.
Inulin significantly decreased coliforms counts (p<0.01), increased lactobacilli counts (p<0.001), and decreased activity of β-glucuronidase (p<0.01) in fresh caecal digesta. Butyric and propionic acids concentrations were increased after inulin supplementation in comparison to DMH group. Application of inulin decreased immunoreactivity and numbers of COX-2, NFκB and iNOS positive cells in colon tissue in comparison to DMH group.
Inulin suppressed expression observed markers, which play an important role in carcinogenesis and in the inflammatory process, which predisposes to the use of inulin in the prevention or treatment of inflammatory bowel disease (Tab. 1, Fig. 2, Ref. 17).
益生元等天然膳食化合物可调节微生物组成,并作为潜在的化学预防剂预防结肠癌的发生。
在实验性化学诱导的二甲基肼诱发的结肠癌发生过程中,研究益生元菊粉对斯普拉格-道利大鼠生化、微生物和化学预防标志物的影响。
将大鼠分为3组:对照组(CG)、二甲基肼组(DMH)和二甲基肼加益生元组(DMH+PRE)。检测益生元菊粉(PRE)对结肠组织中β-葡萄糖醛酸酶活性、短链脂肪酸(SCFA)、大肠菌群和乳酸杆菌计数、环氧合酶-2(COX-2)、转录核因子κB(NFκB)和诱导型一氧化氮合酶(iNOS)免疫反应性的影响。
菊粉显著降低了新鲜盲肠消化物中的大肠菌群计数(p<0.01),增加了乳酸杆菌计数(p<0.001),并降低了β-葡萄糖醛酸酶活性(p<0.01)。与二甲基肼组相比,补充菊粉后丁酸和丙酸浓度增加。与二甲基肼组相比,菊粉的应用降低了结肠组织中COX-2、NFκB和iNOS阳性细胞的免疫反应性和数量。
菊粉抑制了在致癌作用和炎症过程中起重要作用的观察标志物的表达,这使得菊粉在预防或治疗炎症性肠病方面具有应用前景(表1,图2,参考文献17)。